what's glp 1 GLP-1 Agonists: A Comprehensive Overview Science Behind GLP 1 GIP

Ozempic (semaglutide) is a GLP-1 receptor agonist approved for type 2 diabetes

Women are more likely than men to report using GLP-1 drugs while there are not significant differences in use across race and ethnicity

Achieving pharmacoequity will require a major shift in rapidly moving the research continuum from detecting and understanding the root causes of treatment disparities to developing and implementing multilevel evidence-based strategies to eliminate them

17,18 A post hoc analysis of LOOK AHEAD trial data found that participants who achieved at least a 10% body weight loss in the first year had a 21% lower rate of major adverse cardiac events